Medico Intercontinental Limite Share Price

₹ 23.18

+₹0.25 (1.09%)
1D
Last updated 20 Nov, 2026, 15:56 IST
BSE: 539938
|
Investment

Medico Intercontinental Limite Share Price Today

As of 22 Nov 2026, Medico Intercontinental Limite share price is ₹23.18. The stock opened at ₹22.94, compared to its previous close of ₹22.93. During today's trading session, Medico Intercontinental Limite share price moved in the range of ₹22.50 to ₹23.39, with an average price of ₹22.95 for the day. Looking at its last 52-week, the stock has touched a low of ₹20.61 and a high of ₹43.00.

Share price over the last 1 day fell from 23.49 to 23.18, ranging between 22.20 and 23.49.

₹22.50
1.09% up today
₹23.39
1D LOW
1D HIGH

Medico Intercontinental Limite Stock Insights

Latest Earning
Op Profit TrendUp by 111.41% QoQ
Latest Earning
Net Profit TrendUp by 100.49% QoQ
Latest Earning
Revenue TrendUp by 13.24% QoQ
Stock Performance
OutperformingBeat Nifty by 0.86 % in last 6 month
Medico Intercontinental Limite stock performance
Open₹22.94
High₹23.39
Low₹22.50
Prev. close₹22.93
Medico Intercontinental Limite trading activity
Volume461
Average traded price₹22.83
Last traded time03:56:53 20 Nov
Last traded quantity30

Circuit
L
H
₹18.55
₹27.81
52-week
L
H
₹20.61
₹43.00
Mkt Cap Cr
23.18

P/E
-2.9

P/B
0.5

ROA
-6.91%
ROE
-3.64%

ROCE
1.1%

Quick Ratio
1.23

EV/EBITDA
12.66

Based on fundamentals, this stock's

Performance: 1 out of 5, Very Poor
Performance
Very Poor
Medico Intercon. has not beaten FD return of 7%
Valuation: 1 out of 5, Overvalued
Valuation
Overvalued
Medico Intercon. appears overvalued compared to its peers
Earnings: 3 out of 5, Neutral
Earnings
Neutral
Medico Intercon. earnings growth is positive
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,52,298.6441.175.079.61%13.79%18.65%2.3123.67
Divis Laboratories2,97,324.8188.4116.5215.31%18.69%23.83%3.559.25
Torrent Pharmaceuticals1,78,727.2585.159.734.7%11.42%11.37%0.7534.12
Laurus Labs1,24,001.6593.0720.4611.58%22.11%20.91%0.6852.29
Zydus Lifesciences1,19,206.7027.714.297.63%15.1%14.86%0.9116.03
Dr. Reddy's Laboratories1,16,144.5142.092.994.79%7.21%8.58%1.3519.58
Cipla1,14,312.1240.063.236.6%8.18%10.8%2.521.59
Mankind Pharma1,09,869.9948.546.257.82%12.76%14.68%0.7426.67
Aurobindo Pharma1,03,297.5925.912.626.46%10.13%12.76%1.1512.48
Lupin91,915.8917.63.8213.08%21.65%24.54%1.4210.32

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

Medico Intercontinental Limite Company Background

ISIN
INE858Q01019
Sector Market Cap
₹ 23.18 Cr

Medico Intercontinental Ltd is engaged in the business of trading pharmaceutical products. It provides a platform for all research-based biopharmaceutical companies. Its product categories include Gastro, Uro, Nutrition, Cosmetology, Health devices, Hospital, and other areas. Its products include ACIFACT-BLI, ACIFACT-P, ACIFACT-SP (ALU-ALU), ALBECTIN, ALFACARE-D3, ARSUFACT Combokit, BALOFACT, CYCLOFACT 400, UDIFACT 150, XOFACT-4, ZIFT SL-250, ZYMIX, ARGIFACT, CLIANCIACT POWDER, RELIEVE CZ, VOLIREX SPRAY, RACIMAX SACHET, PERMACT, OROFACT, KTZ, FEMYACT, LIVOFACT, ZYMIX SY, ULTRATONE SY, ALBECTIN SUS, BECOFACT DROPS, MEFACT P SUS, ONCARE SOLUTION, OFCARE-FORTE SUS, PRODOM CV SY, RELIBEN SUSP, ZIFT SUSP-200, MGCIPACT EYE DROP, OROFACT-PASTE (lamy), OROFACT MOUTH ULCER GEL, CAMBOGIA, LUBRIACT, HIZEN, and CALAMED LOTION. Its subsidiaries include Evagrace Pharma Private Limited, Ritz Formulations Private Limited, Sungrace Pharma Private Limited, and Azillian Healthcare Private Limited.

Medico Intercontinental Limite Financial Highlights

  • Revenue: Medico Intercontinental Limite reported revenue of ₹85.35 crore in FY26 vs ₹95.74 crore in FY25. It showed a decrease of 10.85% on a yearly basis.
  • Operating Profit: Medico Intercontinental Limite reported an operating loss of ₹9.34 crore in FY26 vs ₹6.82 crore in FY25. It showed a decrease of 236.95% on a year-on-year basis.
  • Net Profit: Medico Intercontinental Limite reported a net loss of ₹11.09 crore in FY26 vs ₹4.96 crore in FY25. It showed a decrease of 323.59% on a yearly basis.

Medico Intercontinental Limite Quarterly Result Highlights

  • Medico Intercontinental Limite reported revenue of ₹23.60 crore in Sep 2026, compared with ₹20.84 crore in Jun 2026, representing an increase of 13.24% on a quarter-on-quarter (QoQ) basis.
  • Medico Intercontinental Limite reported an operating profit of ₹0.42 crore in Sep 2026, compared with ₹3.68 crore in Jun 2026, representing an increase of 111.41% on a quarter-on-quarter (QoQ) basis.
  • Medico Intercontinental Limite reported a profit of ₹0.02 crore in Sep 2026, compared with ₹4.07 crore in Jun 2026, reflecting an increase of 100.49% on a QoQ basis.
  • The earnings per share (EPS) of Medico Intercontinental Limite stood at ₹3.20 during Sep 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters
58.51%
FII
0.00%
Other DII
0.00%
Retail and other
41.49%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Dec 20250.00%
Mar 20260.00%
Jun 20260.00%
Sep 20260.00%

Medico Intercontinental Limite Investment Returns

1 day
+1.09%

1 week
-6.65%

1 month
-6.15%

1 year
-35.88%

3 years
-51.78%

5 years
-51.78%

Medico Intercontinental Limite Share Price History

Medico Intercontinental Limite share price history by day, showing open and close prices and the percentage change
Day
Open / Close
Change %
20 Nov 26
₹22.94 / ₹23.18
+1.09%
19 Nov 26
₹22.58 / ₹22.93
+2.83%
18 Nov 26
₹23.85 / ₹22.30
-3.50%
17 Nov 26
₹24.49 / ₹23.11
-4.43%
Show more

Medico Intercontinental Limite Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹84.08₹95.32₹71.36₹76.23
Other Income₹1.27₹0.42₹0.40₹0.51
Total Revenue₹85.35₹95.73₹71.76₹76.74
Total Expenses₹94.69₹88.91₹66.32₹71.79
Profit Before Tax-₹9.34₹6.82₹5.44₹4.94
Tax₹1.75₹1.87₹1.49₹1.34
Profit After Tax-₹11.09₹4.96₹3.95₹3.61
EPS - Basic-₹3.20₹5.06₹3.95₹5.61
EPS - Diluted-₹3.20₹5.06₹3.95₹5.61

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax-₹9.34₹6.82₹5.44₹4.94
Income before WC changes₹3.44₹8.38₹6.10₹5.58
Change in Assets₹11.94-₹16.43₹7.80-₹16.54
Change in Liabilities₹3.53₹3.59-₹7.03₹2.15
Change in WC₹15.47-₹12.84₹0.77-₹14.39
Cash flow from Operations₹17.08-₹6.26₹5.58-₹10.10
Cash flow from Investing₹2.20-₹4.93-₹8.54-₹5.38
Cash flow from Financing-₹15.56₹10.07-₹0.46₹20.41
Total Cash Flow₹3.72-₹1.12-₹3.42₹4.92
Cash (Start of the year)₹2.24₹3.37₹6.79₹1.87
Cash (End of the year)₹5.96₹2.24₹3.37₹6.79

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹56.01₹22.12₹17.56₹9.18
Current Assets₹61.25₹54.80₹38.48₹49.70
Total Assets₹117.26₹76.92₹56.04₹58.88
Current Liabilities₹37.74₹12.47₹8.99₹15.36
Net Current Asset₹23.51₹42.33₹29.49₹34.34
Non-Current Liabilities₹47.25₹14.36₹2.02₹2.33
Equity Capital₹32.27₹50.09₹45.03₹41.19
Total Equity & Liabilities₹117.26₹76.92₹56.04₹58.88

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹54.46₹67.13₹44.04₹48.88
Other Income₹2.35₹0.51₹0.42₹0.34
Total Revenue₹56.81₹67.64₹44.45₹49.23
Total Expenses₹53.69₹64.06₹41.83₹46.85
Profit Before Tax₹3.12₹3.58₹2.62₹2.38
Tax₹0.93₹1.01₹0.73₹0.67
Profit After Tax₹2.18₹2.57₹1.90₹1.70
EPS - Basic₹2.18₹2.57₹1.90₹2.65
EPS - Diluted₹2.18₹2.57₹1.90₹2.65

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹3.12₹3.58₹2.62₹2.38
Income before WC changes₹3.46₹4.52₹2.74₹2.59
Change in Assets₹9.46-₹14.84₹9.19-₹17.75
Change in Liabilities₹3.57₹4.54-₹5.59₹3.87
Change in WC₹13.03-₹10.30₹3.60-₹13.88
Cash flow from Operations₹15.43-₹6.78₹5.73-₹11.95
Cash flow from Investing₹8.25-₹4.78-₹6.65-₹5.02
Cash flow from Financing-₹22.94₹10.57-₹1.63₹20.63
Total Cash Flow₹0.74-₹0.99-₹2.54₹3.66
Cash (Start of the year)₹1.42₹2.41₹4.95₹1.29
Cash (End of the year)₹2.16₹1.42₹2.41₹4.95

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹40.26₹21.89₹17.43₹10.63
Current Assets₹27.16₹36.88₹22.02₹33.75
Total Assets₹67.42₹58.77₹39.44₹44.38
Current Liabilities₹11.46₹6.95₹2.48₹8.09
Net Current Asset₹15.70₹29.92₹19.53₹25.66
Non-Current Liabilities₹15.12₹13.16₹0.86₹1.99
Equity Capital₹40.85₹38.66₹36.10₹34.30
Total Equity & Liabilities₹67.42₹58.77₹39.44₹44.38
* All values are in INR Crore
Medico Intercontinental Limite market depth
Bid quantityBid priceAsk priceAsk quantity
0023.1710
0000
0000
0000
0000
Total bid quantity0
Total ask quantity10
Medico Intercontinental Limite technical summary
Bearish indicators1
Neutral indicators6
Bullish indicators1
OverallNeutral
by SEBI experts

Expert Pick

EXPPICK
Stop-loss
Stop-loss is locked. Sign in to view.
Entry price
Entry price is locked. Sign in to view.
Target
Target is locked. Sign in to view.
Indicator
Value
Verdict

RSI (14)
42.46
Neutral

ATR (14)
2.12
Neutral

STOCH(9,6)
21.35
Neutral

STOCH RSI (14)
21.8
Neutral

ADX(9)
14.68
Bullish

UO(9)
43.56
Neutral

ROC(12)
-5.54
Bearish

WillR(14)
-78.65
Neutral
Period
Simple value
Exponential vaue

5D
23.14
23.35

10D
24.44
23.9

20D
24.61
24.36

50D
24.94
25

100D
26.05
25.66
Volume trend — traded volume by day
20 Nov0L
19 Nov0L
18 Nov0L
17 Nov0L
16 Nov0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks

Medico Intercontinental Limite
Investment
Add Stock
Add Another

Medico Intercontinental Limite Returns Calculator

Medico Intercontinental Limite Share Price FAQs












Please be aware that Medico Intercontinental Limite stock prices are subject to continuous fluctuations due to various factors.